Jim Cramer says Wall Street is fleeing the AI trade and buying these stocks instead

Market participants are executing a tactical rotation out of memory-chip and AI-infrastructure beneficiaries toward diversified growth names with revenue streams independent of data-center capex cycles. This signals neither euphoria nor panic, but rather portfolio rebalancing as memory-chip valuations face compression from enthusiasm normalization and competitive capacity expansions.

The rotation favors JNJ and similar healthcare, consumer, and industrial names with stable earnings streams and lower correlation to AI capex volatility. This reflects investor fatigue with concentration risk in semiconductor winners like NVDA and AMD, which have priced in multiyear AI buildout assumptions. The shift suggests confidence in broad-based growth without dependence on a single narrative.

Technically, this is a healthy market rotation—not capitulation in AI demand but realization that semiconductor upside may be exhausted in the near term. Institutional flows away from memory-chip plays indicate profit-taking at extremes and capital redeployment into underowned value sectors with lower beta.

Sector implication: Technology sector faces near-term headwinds from semiconductor valuation compression, while Health Care and Consumer Defensive sectors benefit from inflows seeking yield and earnings stability. Broad-market correlation remains low, suggesting a selective reshuffling rather than systemic risk-off environment.